Delisting risk
VolitionRx
Builds blood-based diagnostics from nucleosome measurement and chromatin enrichment.
$0.4091
After-hours close−0.04 (−8.46%)
At close$0.4469(−10.80%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 16.03%Insiders —
Shares outstanding 12.04M · Float 6.66M · 55.3% free float
A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.
Institutions13F, as of Jun 30, 2026
26 holders · 1.93M shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 1.46M | 12.09% | Aug 14, 2026 | |
| Luminus Management LLC | 156.9K | 1.30% | Aug 14, 2026 | |
| Geode Capital Management, LLC | 55.5K | 0.46% | Aug 12, 2026 | |
| Vanguard Capital Management LLC | 50.7K | 0.42% | Aug 13, 2026 | |
| Wealthspire Advisors, LLC | 45.0K | 0.37% | Aug 11, 2026 | |
| State Street Corp | 34.0K | 0.28% | Aug 7, 2026 | |
| XTX Topco Ltd | 25.4K | 0.21% | Aug 14, 2026 | |
| Vanguard Fiduciary Trust Co | 25.1K | 0.21% | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 10.70% | 13G | May 15, 2026 ↗ | |
| Steven Boydincl. Armistice Capital, LLC | 9.99% | Nov 14, 2024 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.